Edgewise Therapeutics (EWTX) is down -9.9%, or -$2.52 to $23.03.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Edgewise Therapeutics Appoints Christopher Martin to Board
- Edgewise Therapeutics price target raised to $34 from $33 at JPMorgan
- Edgewise Therapeutics Appoints New Chief Financial Officer
- Edgewise Therapeutics CFO Michael Carruthers to retire, Michael Nofi to succeed
- Edgewise Therapeutics Reports Q3 2025 Financial Results